Ješeta Michal, Doubravská Adéla, Antalíková Jana, Mekiňová Lenka, Franzová Kateřina, Remundová Kateřina, Hošek Jan, Kempisty Bartosz, Hudeček Robert
Department of Gynecology and Obstetrics, Faculty of Medicine, University Hospital Brno, Masaryk University Brno, Jihlavská 20, 625 00 Brno, Czech Republic.
Laboratory of Reproductive Physiology, Institute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05 Bratislava, Slovakia.
Int J Mol Sci. 2025 Jun 4;26(11):5374. doi: 10.3390/ijms26115374.
The use of microfluidic sperm sorting (MFSS) systems in infertility treatment is increasing due to their practicality and ease of use. While often presented as highly effective, their efficacy in patients with varying sperm analysis results remains uncertain. In this study, we evaluated the effectiveness of MFSS compared with the swim-up (SU) technique in terms of oxygen radical levels and spermiogram parameters. Samples from each patient were processed using both methods, followed by assessments of sperm concentration, motility, morphology, DNA integrity, acrosomal status, and mitochondrial membrane potential. Participants were selected based on sperm analysis and categorized as normozoospermic (n = 40) or non-normozoospermic (n = 28). An analysis of separation techniques revealed no significant differences, except for a lower percentage of DNA-fragmented sperm in the MFSS group compared with SU within the non-normozoospermic cohort (SU: 10.0% vs. MFSS: 5.69%, = 0.027). No differences were observed between SU and MFSS in normozoospermic men. The MFSS method is a simple technique, frequently used in laboratories, that yields good results but does not offer a substantial advantage over SU. The primary benefit of MFSS appears to be a significant reduction in the proportion of sperm with DNA fragmentation compared with SU in patients with abnormal sperm analysis results.
由于其实用性和易用性,微流控精子分选(MFSS)系统在不孕症治疗中的应用正在增加。虽然通常被认为是高效的,但其在精子分析结果各异的患者中的疗效仍不确定。在本研究中,我们从氧自由基水平和精液参数方面评估了MFSS与上游法(SU)相比的有效性。每位患者的样本均采用这两种方法进行处理,随后评估精子浓度、活力、形态、DNA完整性、顶体状态和线粒体膜电位。根据精子分析结果选择参与者,并分为正常精子症患者(n = 40)或非正常精子症患者(n = 28)。对分离技术的分析显示,除了在非正常精子症队列中,MFSS组中DNA片段化精子的百分比低于SU组(SU:10.0% vs. MFSS:5.69%,P = 0.027)外,没有显著差异。在正常精子症男性中,SU和MFSS之间未观察到差异。MFSS方法是一种简单的技术,常用于实验室,能产生良好的结果,但与SU相比没有实质性优势。MFSS的主要益处似乎是与SU相比,在精子分析结果异常的患者中,DNA片段化精子的比例显著降低。